SABATINI, Stefano
 Distribuzione geografica
Continente #
AS - Asia 6.170
NA - Nord America 5.388
EU - Europa 3.967
SA - Sud America 558
AF - Africa 115
OC - Oceania 15
Continente sconosciuto - Info sul continente non disponibili 4
Totale 16.217
Nazione #
US - Stati Uniti d'America 5.280
CN - Cina 2.611
SG - Singapore 1.895
IT - Italia 884
IE - Irlanda 606
HK - Hong Kong 534
UA - Ucraina 499
RU - Federazione Russa 498
VN - Vietnam 492
BR - Brasile 429
SE - Svezia 375
DE - Germania 257
FI - Finlandia 192
FR - Francia 183
GB - Regno Unito 137
KR - Corea 124
IN - India 100
TR - Turchia 71
BE - Belgio 70
PL - Polonia 55
BD - Bangladesh 52
CA - Canada 49
JP - Giappone 49
AR - Argentina 45
IQ - Iraq 45
MX - Messico 41
ES - Italia 38
NL - Olanda 33
PK - Pakistan 30
ZA - Sudafrica 29
ID - Indonesia 27
CH - Svizzera 25
AT - Austria 22
EC - Ecuador 22
UZ - Uzbekistan 21
RO - Romania 20
SA - Arabia Saudita 20
CZ - Repubblica Ceca 18
EG - Egitto 17
MA - Marocco 17
PH - Filippine 17
CL - Cile 14
CO - Colombia 13
VE - Venezuela 13
AU - Australia 11
ET - Etiopia 11
JO - Giordania 11
PT - Portogallo 10
AE - Emirati Arabi Uniti 9
IL - Israele 9
CI - Costa d'Avorio 8
KE - Kenya 8
LT - Lituania 8
PA - Panama 8
PY - Paraguay 8
TN - Tunisia 8
IR - Iran 7
LB - Libano 7
UY - Uruguay 6
AL - Albania 5
BG - Bulgaria 5
KZ - Kazakistan 5
LV - Lettonia 5
AO - Angola 4
GR - Grecia 4
LY - Libia 4
MY - Malesia 4
PE - Perù 4
AZ - Azerbaigian 3
DK - Danimarca 3
HR - Croazia 3
NZ - Nuova Zelanda 3
QA - Qatar 3
SY - Repubblica araba siriana 3
AM - Armenia 2
BO - Bolivia 2
BY - Bielorussia 2
DO - Repubblica Dominicana 2
DZ - Algeria 2
EU - Europa 2
HU - Ungheria 2
JM - Giamaica 2
KG - Kirghizistan 2
LK - Sri Lanka 2
NO - Norvegia 2
NP - Nepal 2
OM - Oman 2
RS - Serbia 2
TH - Thailandia 2
TT - Trinidad e Tobago 2
TW - Taiwan 2
XK - ???statistics.table.value.countryCode.XK??? 2
AF - Afghanistan, Repubblica islamica di 1
BA - Bosnia-Erzegovina 1
BF - Burkina Faso 1
BH - Bahrain 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
EE - Estonia 1
Totale 16.200
Città #
Guangzhou 2.080
Singapore 1.401
Chandler 774
Dublin 606
Hong Kong 522
San Jose 495
Perugia 455
Ashburn 320
San Mateo 293
Dong Ket 276
Jacksonville 272
Boardman 201
Santa Clara 192
Moscow 151
Medford 133
Princeton 133
Lauterbourg 128
Beijing 127
Seoul 121
Los Angeles 106
Ann Arbor 101
Wilmington 99
Altamura 91
Andover 79
The Dalles 78
Ho Chi Minh City 75
Munich 75
New York 73
Brussels 70
Lawrence 70
São Paulo 55
Piscataway 52
Turku 50
Hanoi 49
Orem 48
Fremont 47
Redmond 46
Warsaw 45
Tokyo 42
Des Moines 39
Saint Petersburg 36
Brooklyn 30
Dearborn 30
Rome 29
Dallas 28
Atlanta 27
Helsinki 26
Montreal 26
Council Bluffs 25
Norwalk 24
Chicago 23
Izmir 23
Baghdad 22
Falls Church 20
West Jordan 20
Denver 19
Phoenix 19
Spoleto 19
Stockholm 19
Ankara 18
Chennai 18
Houston 18
Woodbridge 18
Poplar 17
Seattle 17
Johannesburg 16
London 16
Hefei 15
Rio de Janeiro 15
Shanghai 15
Mexico City 14
Redwood City 14
Secaucus 14
Boston 13
Columbus 13
Mumbai 13
Porto Alegre 13
Vienna 13
Amsterdam 12
Charlotte 12
San Diego 12
Bologna 11
Buffalo 11
Addis Ababa 10
Barnet 10
Brasília 10
Cairo 10
Da Nang 10
Den Haag 10
Dhaka 10
Manchester 10
Nuremberg 10
San Paolo di Civitate 10
Tashkent 10
Belo Horizonte 9
Frankfurt am Main 9
Lappeenranta 9
Querétaro 9
San Francisco 9
San Giustino 9
Totale 11.047
Nome #
Structural investigation of Small Molecules Targeting Influenza A Virus Polymerase 2.139
1,2,4-triazolo[1,5-α]pyrimidines as a novel class of inhibitors of the HIV-1 reverse transcriptase-αssociated ribonuclease h activity 330
1,4-Benzothiazine ATP-Sensitive Potassium Channel Openers: Modifications at the C-2 and C-6 Positions 317
Sintesi di nuovi inibitori della pompa di efflusso NorA dello S. aureus: dalle 3-fenil-1,4-benzotiazine alle 2-fenilchinossaline 164
Alternate NF-κB-independent signaling reactivation of latent HIV-1 provirus 158
Functionalized 2,1-benzothiazine 2,2-dioxides as new inhibitors of Dengue NS5 RNA-dependent RNA polymerase 154
Derivati benzotiazinici come inibitori della pompa estrudente MDR NorA dello Staphylococcus aureus 145
Antitubercular polyhalogenated phenothiazines and phenoselenazine with reduced binding to CNS receptors 145
SINTESI DI NUOVI INIBITORI DELLA POMPA DI EFFLUSSO NorA DELLO S. aureus: DALLE 3-FENIL-1,4-BENZOTIAZINE ALLE 2-FENILCHINOLINE 142
2-Phenylquinolones as Inhibitors of the HIV-1 Tat/TAR Interaction. 141
Attivatori dei canali K-ATP a struttura 1,4-benzotiazinica: modificazioni in C-2 e C-6 140
C-2 phenyl replacements to obtain potent quinoline-based Staphylococcus aureus NorA inhibitors 140
A 1,8-Naphthyridone Derivative Targets the HIV-1 Tat-Mediated Transcription and Potently Inhibits the HIV-1 Replication. 139
Efficient microwave assisted synthesis of metal-organic framework UiO-66: optimization and scale up 139
A Broad Anti-influenza Hybrid Small Molecule that Potently Disrupts the Polymerase Acidic Protein-Basic Protein 1 (PA-PB1) Subunits Interaction 137
New anti-ovarian cancer quinolone derivatives acting by modulating microRNA processing machinery 135
Derivati 2-fenilchinolonici come inibitori della pompa di efflusso NorA dello Staphylococcus aureus ciprofloxacin resistente 134
2-phenylquinolones as HIV-1 Tat/TAR interaction inhibitors 132
8-Methyl-7-substituted-1,6-naphthyridine-3-carboxylic Acids as New 6-Desfluoroquinolone Antibacterials 132
2-Phenylquinoline S. aureus NorA Efflux Pump Inhibitors: Evaluation of the Importance of Methoxy Group Introduction 132
From Quinoline to Quinazoline-Based S. aureus NorA Efflux Pump Inhibitors by Coupling a Focused Scaffold Hopping Approach and a Pharmacophore Search 129
A New Promising Class of pyrazolobenzothiazine inhibitors of S. aureus NorA Efflux Pump 128
Syhtesis and Biological Evaluation of 2-Phenylquinolones Targeted at Tat/TAR Recognition 127
6-Hydrogen-8-Methylquinolones Active Against Replicating and Non-replicating Mycobacterium tuberculosis 126
Discovery of potent p38α MAPK inhibitors through a funnel like workflow combining in silico screening and in vitro validation 125
Pyridobenzothiazolones Exert Potent Anti-Dengue Activity by Hampering Multiple Functions of NS5 Polymerase 124
6-Desfluoroquinolones as promising HIV transcription inhibitors 123
Structure-activity relationship study on anti-HIV 6-desfluoroquinolones. 122
Studies on 6-Aminoquinolones: Synthesis and Antibacterial Evaluation of 6-Amino-8-ethyl- and 6-Amino-8-methoxyquinolones 122
Binding studies and GRIND/ALMOND-based 3D QSAR analysis of benzothiazine type K-ATP channel openers 121
Investigation of targeted pyrrolizidine alkaloids in traditional Chinese medicines and selected herbal teas sourced in Ireland using LC-ESI-MS/MS 119
Inhibition of Staphylococcus pseudintermedius Efflux Pumps by Using Staphylococcus aureus NorA Efflux Pump Inhibitors 117
Discovery of Novel Inhibitors of the NorA Multidrug Transporter of Staphylococcus aureus. 117
A GRIND based pharmacophoric model for Factor Xa inhibitors 116
S. aureus NorA efflux pump: the discovery of new potent inhibitors 115
Computer-Aided Identification of Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 115
From cycloheptathiophene-3-carboxamide to oxazinone-based derivatives as allosteric HIV-1 ribonuclease H inhibitors 115
Targeting CDKs to inhibit the HIV-1 TAT-mediated transcription 114
Broad spectrum anti-flavivirus pyridobenzothiazolones leading to less infective virions 111
Disegno di nuovi chinoloni ad attività antitubercolare: dalla 3D-QSAR agli algoritmi evolutivi. 110
Ethidium bromide exposure unmasks an antibiotic efflux system in Rhodococcus equi 110
Accounting for target flexibility and water molecules by docking to ensembles of target structures: The HCV NS5B Palm Site I inhibitors case study. 110
Synthesis and Characterization of 1,2,4-Triazolo[1,5-a]pyrimidine-2-carboxamide-based Compounds Targeting the PA-PB1 Interface of Influenza A Virus Polymerase. 110
From 6-Aminoquinolone Antibacterials to 6-Amino-7-thiopyranopyridinylquinolone Ethyl Esters as Inhibitors of Staphylococcus aureus Multidrug Efflux Pumps. 109
RE-EVOLUTION OF THE 2-PHENYL-4-HYDROXYQUINOLINES: OPTIMIZATION OF A POTENT NEW CLASS OF S. AUREUS NorA EFFLUX PUMP INHIBITORS 109
Deciphering the molecular recognition mechanism of multidrug resistance staphylococcus aureus nora efflux pump using a supervised molecular dynamics approach 109
A new 6-aminoquinolone compound with anti-HCMV activity 108
New Pyrazolobenzothiazine Derivatives As Hepatitis C Virus NS5B Polymerase Palm Site I Inhibitors 107
Biofunctionalization of Poly(lactide-co-glycolic acid) Using Potent NorA Efflux Pump Inhibitors Immobilized on Nanometric Alpha-Zirconium Phosphate to Reduce Biofilm Formation 107
p38 alpha MAPK and Type I Inhibitors: Binding Site Analysis and Use of Target Ensembles in Virtual Screening 105
Antiviral Activity of WC5, a new 6-aminoquinolone compound against Human Herpesviruses 104
2-Phenylquinazolinone fragment imparts anti-CDKs and anti-HIV activities 104
CYCLOHEPTATHIOPHENE-3-CARBOXAMIDE DERIVATIVES AS INFLUENZA A VIRUS POLYMERASE INHIBITORS 104
Highly Potent 1,4-Benzothiazine Derivatives as KATP-Channel Openers 103
Derivati 1,4-benzotiazinici come agenti anticonvulsivanti. 103
Investigation on the effect of known potent S. aureus NorA efflux pump inhibitors on the staphylococcal biofilm formation 103
Structural Modifications of the Quinolin-4-yloxy Core to Obtain New Staphylococcus aureus NorA Inhibitors 103
Evolution from a natural flavones nucleus to obtain 2-(4-Propoxyphenyl)quinoline derivatives as potent inhibitors of the S. aureus NorA efflux pump. 101
Synthesis of Novel Inhibitors of the S. aureus Efflux pumps: from the 4-hydroxy-2-phenylquinolines to the 4-hydroxy-2-phenylquinazolines 101
Pharmacophore-Based Repositioning of Approved Drugs as Novel Staphylococcus aureus NorA Efflux Pump Inhibitors 101
Computer-Aided Design, Synthesis and Validation of 2-Phenylquinazolinone Fragments as CDK9 Inhibitors with Anti-HIV-1 Tat-Mediated Transcription Activity 100
Impact of conventional/non-conventional extraction methods on the untargeted phenolic profile of Moringa oleifera leaves 99
Searching for Novel Inhibitors of the S. aureus NorA Efflux Pump: Synthesis and Biological Evaluation of the 3-Phenyl-1,4-benzothiazine Analogues 98
Efficient and regioselective one-step synthesis of 7-aryl-5-methyl- and 5-aryl-7-methyl-2-amino-[1,2,4]triazolo[1,5-a] pyrimidine derivatives 98
Small Molecules as HIV-1 Tat-TAR Complex Inhibitors 97
Synthesis of 2-(Arylamino)ethanethiols via Lewis Acid catalyzed Aminolysis of 2,2-Dimethylthiirane as Precursors of the 1,4-Benzothiazine Nucleus 97
Studies on 2-phenylquinoline Staphylococcus aureus NorA efflux pump inhibitors: New insights on the C-6 position 97
Searching for innovative quinolone-like scaffolds: synthesis and biological evaluation of 2,1-benzothiazine 2,2-dioxide derivatives 96
Pyrazolobenzothiazines as potent TNF-alpha production inhibitors. 96
The Pyrazolobenzothiazine Core as a New Chemotype of p38 Alpha Mitogen-Activated Protein Kinase Inhibitors 96
Sustainable, three-component, one-pot procedure to obtain active anti-flavivirus agents 95
New C-6 functionalized quinoline NorA inhibitors strongly synergize with ciprofloxacin against planktonic and biofilm growing resistant Staphylococcus aureus strains 92
Pyridobenzothiazole derivatives as new chemotype targeting the HCV NS5B polymerase 92
Structural optimization of the 2-Phenyl-4-hydroxyquinoline Class of S. aureus NorA Efflux Pump Inhibitors 92
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 91
6-desfluorochinoloni (6-DFQ): sintesi assistita da microonde di 6-amino-7-(4-oxopiridinil) e 6-amino-7-(benzo-4-oxopiridinil) chinoloni 91
Structure-based insights into p38α MAPK: from crystal structures analysis to hit optimization 91
Fighting Antimicrobial Resistance: Insights on How the Staphylococcus aureus NorA Efflux Pump Recognizes 2-Phenylquinoline Inhibitors by Supervised Molecular Dynamics (SuMD) and Molecular Docking Simulations 91
Studies on Anti-HIV Quinolones: New Insights on the C-6 Position 90
Ligand Promiscuity between the Efflux Pumps Human P-Glycoprotein and S. aureus NorA 90
Nuovi Tiopiranopiridinil Chinoloni 89
Natural isoflavone biochanin A as a template for the design of new and potent 3-phenylquinolone efflux inhibitors against Mycobacterium avium 89
Building up efflux-mediated antimicrobial resistance in Staphylococcus pseudintermedius 87
Modifications on C6 and C7 Positions of 3-Phenylquinolone Efflux Pump Inhibitors Led to Potent and Safe Antimycobacterial Treatment Adjuvants 87
Structure modifications of 6-aminoquinolones with potent anti-HIV activity 86
Functionalized sulfonyl anthranilic acid derivatives inhibit replication of all the four dengue serotypes 85
Structural Modifications of 2-phenylquinoline Inhibitors of S. aureus MDR NorA efflux pump 85
Drug efflux transporters in Staphylococcus pseudintermedius: in silico prediction and characterization of resistance 83
Cycloheptathiophene-3-carboxamide derivatives as influenza A virus polymerase inhibitors 83
Biotinylated Tryptophan Catabolites for Target Fishing. 83
Novel 1,4-Benzothiazine Derivatives as large conductance Ca2+-activated potassium channel activators 82
Impact of conventional and non-conventional extraction methods on the untargeted phenolic profile of Moringa oleifera leaves 82
Design and Synthesis of Modified Quinolones as Antitumoral Acridones 81
Studi di molecular modeling per il disegno di inibitori COX-2 selettivi. 81
Identification of Anti-Influenza A Compounds Inhibiting the Viral Non-Structural Protein 1 (NS1) Using a Type I Interferon-Driven Screening Strategy 80
Novel 1,4-Benzothiazine Derivatives as Large Conductance Ca2+-Activated Potassium Channel Openers 80
Boosting Effect of 2-Phenylquinoline Efflux Inhibitors in Combination with Macrolides against Mycobacterium smegmatis and Mycobacterium avium 80
Mode of action of the 2-phenylquinoline efflux inhibitor PQQ4R against Escherichia coli 80
In Vitro and In Vivo Investigations into the Potential of Quinazoline and Quinoline Derivatives as NorA Efflux Pump Inhibitors Against Resistant Staphylococcus aureus Strains 78
Searching New HCV NS5B Polymerase Inhibithors 78
Totale 13.250
Categoria #
all - tutte 61.358
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 61.358


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021427 0 0 0 0 0 0 0 0 0 44 86 297
2021/20221.250 34 195 17 71 97 12 50 364 54 33 162 161
2022/20232.236 141 340 36 212 193 236 16 130 799 13 80 40
2023/20243.109 73 145 52 20 21 26 2.303 21 133 49 121 145
2024/20252.494 40 193 105 223 272 145 258 136 440 136 353 193
2025/20264.900 341 329 222 667 732 515 873 254 567 400 0 0
Totale 16.624